The Class D medical device MDACS registration process in Hong Kong involves a structured pathway managed by the Medical Device Division (MDD) under the Department of Health (DoH). Class D devices are categorized as high-risk, including life-sustaining, implantable, or critical care devices such as pacemakers, dialysis systems, and heart valves.
Below is a comprehensive breakdown of the process, required documents, and key considerations:
Refer to:
TR-003 – Classification of General Medical Devices
TR-006 – Classification of In Vitro Diagnostic (IVD) Devices
Class D includes:
Devices in contact with the central circulatory or nervous system
Devices used for life support or life-sustaining purposes
High-risk IVDs (e.g., HIV, blood grouping)
Required for all non-Hong Kong manufacturers.
The LRP must:
Be a Hong Kong-registered business
Submit the application via MDIS
Maintain post-market compliance (vigilance, recalls, reporting)
(See full list in Section II below)
Online-only submission as of April 2024
Register an MDIS account under the LRP’s name
Fill in product info, upload documents, and submit
MDD will:
Validate completeness of submission
Review technical content and overseas certifications
Request additional documents if needed
No fee is currently charged (MDACS is voluntary)
Upon successful review, MDD will issue:
Device listing number
Device listing on the MDACS official database
Listing is valid for 5 years, renewable
| Document | Description |
|---|---|
| ✅ MDACS Application Form | MD-1 form (via MDIS system) |
| ✅ Device Description | Overview, intended use, technical specs, features |
| ✅ Declaration of Conformity | Signed by the manufacturer; complies with Essential Principles (GN-01, GN-02) |
| ✅ Approval in GHTF Country | Regulatory certificate or Free Sale Certificate (e.g., CE, FDA, TGA, NMPA, etc.) |
| ✅ ISO 13485 Certificate | Manufacturer’s Quality Management System certificate issued by accredited body |
| ✅ Risk Management Report | Per ISO 14971; includes risk analysis, mitigation, residual risk |
| ✅ Clinical Evaluation Report (CER) | Literature review or trial data showing safety/performance |
| ✅ Labeling & Instructions for Use (IFU) | In English and/or Traditional Chinese; must include warnings, manufacturer & LRP details |
| ✅ Technical File Summary | Summarized version of design and manufacturing data |
| ✅ Post-Market Surveillance Plan | Adverse event reporting, recalls, trend analysis |
| ✅ Test Reports (if applicable) | Electrical safety (IEC 60601 series), EMC, biocompatibility, sterility, software validation, etc. |
| ✅ UDI Information | If applicable, include Unique Device Identifier |
At least one prior approval from a recognized jurisdiction (EU, US, Australia, Japan, Canada, China, Korea, Singapore) is mandatory.
Certificates must be current and valid.
The LRP must:
Handle all communication with MDD
Respond to queries within deadlines
Submit vigilance reports (adverse events, recalls)
Maintain device traceability and update changes to labeling or design
Files must be uploaded through MDIS in PDF format.
Labeling must be clear and in acceptable language(s).
All certificates must be translated into English or Chinese if originally in another language.
Mandatory for Class D devices
Acceptable forms:
Peer-reviewed literature
Clinical investigation reports
Real-world evidence from recognized countries
Preparation of dossier: 1–3 months
Review time: 3–9 months (depending on complexity and responsiveness)
No official expedited route as of now
MDACS is voluntary and does not currently require payment for registration.
This may change when the Medical Device Ordinance becomes law.
| Step | Details |
|---|---|
| Classification | Confirm as Class D via TR-003 / TR-006 |
| Local Representative | Must be a Hong Kong-based LRP |
| Submission System | MDIS (online platform) |
| Required Approvals | At least one from GHTF country |
| Application Documents | Technical dossier, certificates, risk report, CER, labeling |
| Post-Market Duties | AE reporting, recalls, change notification |
| Application Fee | None (currently) |
| Listing Validity | 5 years |
| Estimated Review Timeline | 3–9 months |

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn